JP TSE 4883 Pharmaceutical

Modalis Therapeutics Corporation

株式会社モダリス

Net income

−¥2.2B

≈ −$13.6M

Total assets

¥3.0B

≈ $18.8M

Equity ratio

94.2%

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Total assets	Net assets	Equity ratio	Source
Dec 2025	—	−¥2.2B	¥3.0B	¥2.8B	94.2%	EDINET (consol.)
Dec 2024	—	−¥1.3B	¥3.7B	¥3.5B	96.1%	EDINET (consol.)
Dec 2023	—	−¥2.4B	¥2.0B	¥1.4B	68.1%	EDINET (consol.)
Dec 2022	—	−¥2.7B	¥3.1B	¥2.9B	94.0%	EDINET (consol.)
Dec 2021	—	−¥739M	¥6.1B	¥5.5B	91.4%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.